Real-Life Use of Bendamustine for B-Cell Non-Hodgkin Lymphoma in a Community Hospital in Japan-Retreatment With Bendamustine Is Safe and Feasible

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_196
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Real-World Bendamustine Use in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Bendamustine-Based Therapy as First-Line Treatment for Non-Hodgkin Lymphoma

Medical Oncology
MedicineCancer ResearchOncologyHematology
2014English

Differences in Quality of Life Between Bendamustine-Rituximab and R-Chop/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Pegfilgrastim in Primary Prophylaxis of Febrile Neutropenia Following Frontline Bendamustine Plus Rituximab Treatment in Patients With Indolent Non-Hodgkin Lymphoma: A Single Center, Real-Life Experience

Supportive Care in Cancer
Oncology
2016English

Brentuximab-Vedotin and Bendamustine Is a Feasible and Effective Drug Combination as First-Line Treatment of Hodgkin Lymphoma in the Elderly (Halo Trial)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Combination of Nivolumab and Bendamustine in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2016English

Combination of Pim Kinase Inhibitor SGI-1776 and Bendamustine in B-Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Bendamustine-Based Conditioning for Non-Hodgkin Lymphoma Autologous Transplantation: An Increasing Risk of Renal Toxicity

Bone Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy